Lilly shares safety, tolerability data on its next-gen obesity drug

Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association on Saturday.

https://www.statnews.com/2026/06/06/illy-retatrutide-triple-g-weight-loss-obesity-safety-data-ada/

#TopNews #News #Lilly #theAmericanDiabetesAssociation #TRANSCEND